Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Cataract & MIGS · New York | Cataract & MIGS · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 588 | 390 |
| Medicare fee-for-service cases | 82,565 | 72,726 |
| Growth since 2019 (Medicare FFS) | −2.7%/yr | −1.7%/yr |
| Forecast cases (Medicare FFS) | 85,900 in 2030 | 74,300 in 2030 |
| Forecast growth | +0.7%/yr to 2030 | +0.4%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 44.5 | 52.4 |
| Medicare Advantage share | 57% | 58% |
| Out of hospital | 75% (+9 pts since 2019) | 80% (+2 pts since 2019) |
| Cases per surgeon | 140 | 186 |
| Top 10 surgeons' share | 9% | 11% |
| Surgeons growing | 187 | 149 |
| New since the base year | 76 | 51 |
| Likely to stop billing it | 40 by 2026 | 15 by 2026 |
| Forecast miss, 1 year (procedure) | 7% | 7% |
| Company payments per surgeon | $1,562 | $3,068 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.